等待开盘 03-26 09:30:00 美东时间
+0.020
+1.74%
Horizon will provide Hyperfine with an initial funding of $15 million at closing, and up to $25 million available to support future commercial growth.
03-23 20:13
今日重点评级关注:RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从32美元升至35美元;巴克莱:维持CytomX医疗"超配"评级,目标价从10美元升至16美元
03-20 15:53
Hyperfine Inc. (($HYPR)) has held its Q4 earnings call. Read on for the main hi...
03-20 08:07
Lake Street analyst Frank Takkinen maintains Hyperfine (NASDAQ:HYPR) with a Buy and raises the price target from $2 to $2.5.
03-20 04:30
Hyperfine ( ($HYPR) ) has shared an update. On March 18, 2026, Hyperfine, Inc. ...
03-19 04:58
Hyperfine (NASDAQ:HYPR) sees FY2026 sales of $20.000 million-$22.000 million vs $18.000 million analyst estimate.
03-19 04:06
Hyperfine (NASDAQ:HYPR) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.08) by 25 percent. This is a 57.14 percent increase over losses of $(0.14) per share from the same
03-19 04:05
Companies Reporting Before The Bell • SailPoint (NASDAQ:SAIL) is estimated to r...
03-18 19:11
Hyperfine to present Swoop portable MRI at Akutveckan 2026 Hyperfine will attend Akutveckan 2026 on March 11-13, 2026, at Elite Hotel Marina Tower in Stockholm, where Lioness Medtech will showcase the Swoop portable MRI system. Rui Teixeira is scheduled to present “Hyperfine Swoop Portable MRI” on M
03-10 17:28
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced
01-27 21:18